Antirheumatic effect of IDS 23, a stinging nettle leaf extract, on in vitro expression of T helper cytokines

Journal of Rheumatology

Volumn 26, Issue 12, 1999, Pages 2517-2522

  Klingelhoefer, Sonja ^a   Obertreis, Barbara ^a   Quast, Sabine ^a   Behnke, Bert ^a  

^a Strathmann Research GmbH   (Germany)

Author keywords

Interferon ; Interleukin 2; Interleukin 4; Rheumatoid arthritis; T helper effector cells; Therapy

Indexed keywords

ACTIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PHYTOHEMAGGLUTININ; URTICA DIOICA EXTRACT;

ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONONUCLEAR CELL; NORMAL HUMAN; PLANT LEAF; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; CARCINOGENS; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; JURKAT CELLS; PHYTOHEMAGGLUTININS; PLANT EXTRACTS; PLANT LEAVES; PLANT LECTINS; RHEUMATIC DISEASES; T-LYMPHOCYTES, HELPER-INDUCER; TETRADECANOYLPHORBOL ACETATE;

EID: 0032735490     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Lanchbury JS, Pitzalis C. Cellular immune mechanisms in rheumatoid arthritis and other inflammatory arthritides. Curr Opin Immunol 1993;5:918-24.
2. Alarcon GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin N Am 1995;21:589-604.
3. Goronzy JJ, Weyand CM. T and B cell-dependent pathways in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:214-21.
4. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T Cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
5. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
6. Thompson-Snipes L. Interleukin 10, a novel stimulating factor for mast cells and their progenitors. J Exp Med 1991;173:507-10.
7. Coffman RL, Carty J. A T cell activity that enhances polydonal IgE production and its inhibition by interferon-γ J Immunol 1986;136:949-54.
8. Sanderson CJ, O'Garra AO, Warren DJ, Klaus GG. Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sci USA 1986;83:437-40.
9. Espinoza-Delgado J, Bosco MC, Musso T, Gusella GL, Longo DL, Varesio L. Interleukin-2 and human monocyte activation. J Leukoc Biol 1995;57:13-9.
10. Arner EC, Tororella MD. Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergize with interleukin-1. Arthritis Rheum 1995;9:1304-14.
11. Malfait AM, Verbruggen G, Veys EM, Lambert J, Deridder L, Cornelissen M. Comparative and combined effects of interleukin-1ß and tumor necrosis factor-α on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 1994; 21:314-20.
12. Bathon JM, Hwang JJ, Shin LH, Precht PA, Towns MC, Horton WE. Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1. Arthritis Rheum 1994;37:1350-6.
13. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin-1 - comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6.
14. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993;14:335-8.
15. Jacobson NG, Szabo SJ, Weber-Nordt RM, et al. Interleukin 12 signaling in T helper type 1 cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995;181:1755-62.
16. Germann T, Szeliga J, Hess H, et al. Administration of interleukin-12 in combination with type-II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci USA 1995;92:4823-7.
17. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-9.
18. Hseih CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992;89:6065-9.
19. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635-73.
20. Maini RN. A perspective on anti-cytokine and anti-T cell-directed therapies in rheumatoid arthritis. Clin Exp Rheumatol 1995; 13:S35-40.
21. Van de putte LBA, Van Riel PLCM. Rheumatoid arthritis - new trends in therapy. Clin Exp Rheumatol 1995;13:S27-30.
22. Martini R. Urticae herba, Urticae folium [Stinging nettle herb, stinging nettle leaf. Product licences and registrations of drugs under the German drug law of 1976]. Zulassungen und Registrierungen von Arzneimitteln nach dem AMG'76 (Erg-Lieferung) 1990:28.
23. Bundesgesundheitsamt. Monographie: Urtica herba, Brennesselkraut; Urticae folium, Brennesselblätter [Monograph: Urtica herba, stinging nettle herb; Urticae folium, stinging nettle leaf]. Bundesanzeiger 1987; August 3: 76.
24. Lutomski J, Speichert H. Die Brennessel in Heilkunde und Ernährung [Use of stinging nettle in medicine and nourishment]. Pharm Unserer Zeit 1983;12:181-6.
25. Weiss RF. Lehrbuch der Phytotherapie [Textbook of herbal therapy]. Stuttgart: Hippokrates; 1991:335-6.
26. Wichtl M. Teedrogen: Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage [Tea drugs. A handbook for science based practice]. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1989: 590-2.
27. Madaus G. Lehrbuch der Biologischen Heilmittel [Textbook of biological remedies]. Hildesheim: Georg Olms Verlag; 1979; 3:2746-54.
28. Ramm S, Hansen C. Multizentrische Anwendungsbeobachtungen mit Rheuma-Hek: Brennesselblätter-Extrakt bei Arthrose und rheumatoider Arthritis [Multicentric postmarketing surveillance study with Rheuma-Hek: use of stinging nettle extract for therapy of osteoarthritis and rheumatoid arthritis]. Therapie Woche 1996;28:3-6.
29. Ramm S, Hansen C. Brennesselblätter-Extrakt bei rheumatischen Beschwerden [Use of stinging nettle leaf extract for therapy of rheumatic pain]. Dtsch Apoth Ztg 1995;39:3-8.
30. Wolf F. Gonarthrose - Brennesselblätter-Extrakt IDS 23 in der Langzeitanwendung. [Gonarthritis - stinging nettle leaf extract IDS 23 in long term application.] Der Kassenarzt 1998;44:52-4. [Reference added in proof]
31. Teucher T, Obertreis B, Ruttkowski T, Schmitz H. Zytokin-Sekretion im Vollblut gesunder Probanden nach oraler Einnahme eines Urtica dioica L.-Blattextraktes [Cytokine secretion in whole blood of healthy volunteers after oral ingestion of an Urtica dioica leaf extract]. Arzneim-Forsch/Drug Res 1996;46:906-10.
32. Obertreis B, Ruttkowski T, Teucher T, Behnke B, Schmitz H. Ex vivo in vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-α and interleukin-1ß secretion in human whole blood by extractum Urticae dioicae foliorum. Arzneim-Forsch/Drug Res 1996;46:389-94.
33. Obertreis B, Giller K, Teucher T, Behnke B, Schmitz H. Antiphlogistische Effekte von Extractum Urtica dioica foliorum im Vergleich zu Kaffeoyläpfelsäure [Antiphlogistic effects of Urtica dioica folia extract in comparison to cafeic malic acid]. Arzneim/Drug Res 1996;46:52-6.
34. Moulton PJ. Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species. Br J Biomed Sci 1996;53:317-24.
35. Allen JN, Herzyk DJ, Allen ED, Wewers MD. Human whole blood interleukin-1ß production: Kinetics, cell source, and comparison with TNF-α. J Lab Clin Med 1992;119:538-46.
36. Yamamoto N, Sakai F, Yamazaki H, Kawai Y, Nakahara K, Okuhara M. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. J Rheumatol 1996;23:1778-83.
37. Gillis S, Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med 1980;152:1709-19.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
39. Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of 3-(4,5-Dimethylthiazol-2-yl) -2,5-diphenyl-tetrazonium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989;49:4435-40.
40. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
41. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α, MIP-1ß, and RANTES is associated with type 1 immune response. J Immunol 1996;157:3598-604.
42. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
43. Theze J, Alzari PM, Bertoglio J. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today 1996;17:461-8.
44. Waldmann TA, The IL2/IL-2 receptor system. A target for rational immune intervention. Immunol Today 1993;14:264-70.
45. Elliott MJ, Maini RN, Feldmann M, et al. Repeated therapy with monoclonal antibody to tumor necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125-7.
46. Bach JF. Immunosuppressive therapy of autoimmune diseases. Immunol Today 1993;14:322-6.
47. Tanaka T, Hu-Li J, Seder RA, de St Groth BF, Paul WE. Interleukin suppresses interleukin-2 and interferon-gamma production by native T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 1993;90:5914-8.
48. Röcken M, Racke M, Shevach EM. IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996;17:225-31.
49. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-51.
50. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
51. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 downregulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989;142:3857-61.
52. 2. Proc Natl Acad Sci USA 1989;86:3803-7.
53. te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG. Interleukin-4 (IL-4) inhibits secretion of IL-1ß, tumor necrosis factor-α and IL-6 by human monocytes. Blood 1990;76:1392-7.
54. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/ gelatinase production by human monocytes. J Biol Chem 1992;267:515-9.
55. Abramson SL, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1990;144:625-30.
56. Zhou Y, Lin G, Murtaugh MP. Interleukin-4 suppresses the expression of macrophage NADPH oxidase heavy chain subunit (gp91-phox). Biochim Biophys Acta 1995;1265:40-8.
57. Schlaak JF, Schwarting A, Knolle P, Meyer zum Büschenfelde K-H, Mayet W. Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts. Ann Rheum Dis 1995;54:560-5.
58. Elliott MJ, Gamble JR, Park LS, Vadas MA, Lopez AF. Inhibition of human monocyte adhesion by interleukin 4. Blood 1991;77:2739-45.
59. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993;14:270-4.
60. Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-6.
61. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
62. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicão-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993;91:1390-5.
63. Deleuran B, Iversen L, Kristensen M, et al. Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: In vivo antiinflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein. Br J Rheumatol 1994;33:520-5.
64. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukins-10 and -4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995;38:1046-54.
65. de Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
66. van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.